Project 3: Analysis of intrinsic and extrinsic factors that promote prostate neuroendocrine differentiation
Project 3: Analysis of intrinsic and extrinsic factors that promote prostate neuroendocrine differentiation
批准号:
10612357
负责人:
MICHAEL M. SHEN
金额:
$42.67万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-05-01 至 2027-04-30
关键词:
AbateAddressAndrogen AntagonistsAndrogen ReceptorAndrogensBioinformaticsBiological AssayCandidate Disease GeneCellsClinicalCollaborationsComparative StudyComputer AnalysisDataDevelopmentDiseaseEnvironmentEpitheliumFGFR1 geneGenerationsGenetic Complementation TestGenetically Engineered MouseHeterogeneityHumanIntrinsic factorInvestigationLigandsMalignant NeoplasmsMalignant neoplasm of prostateMesenchymeModelingMolecularMolecular AnalysisMolecular TargetMusNCAM1 geneNeuroendocrine CellNeuroendocrine Prostate CancerNeurosecretory SystemsOrganogenesisOrganoidsPathway interactionsPatternPrimary NeoplasmProstateProstatic NeoplasmsReceptor InhibitionRoleSamplingSignal TransductionSpecific qualifier valueSystemTissue RecombinationTissue SampleTissuesValidationVisualizationWNT Signaling PathwayWorkcandidate identificationcastration resistant prostate cancercell typecomparativedata managementdeprivationeffective therapyhuman tissuein vivoinnovationinterestmouse modelmultiplexed imagingneoplastic cellneuroendocrine differentiationneuroendocrine phenotypenovelprepubertyprogramsprostate cancer cellreceptorresponsesingle-cell RNA sequencingsynergismtherapeutic targettherapy resistanttranscription factortransdifferentiationtranslational impacttumortumor microenvironmenttumorigenic
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
The clinical use of potent anti-androgens has promoted the emergence of novel forms of castration-
resistant prostate cancer (CRPC), including neuroendocrine prostate cancer (NEPC), which is highly aggressive
and lethal. To date, relatively little is known about the regulatory programs for specification of rare
neuroendocrine cells in the normal prostate, or how they might be recapitulated or altered during neuroendocrine
differentiation in prostate cancer. Therefore, we will pursue a comparative analysis of neuroendocrine
specification in the normal and transformed prostate to elucidate similarities and differences in their regulatory
programs. In preliminary studies of prostate organogenesis, our findings suggest that prostate neuroendocrine
cells are generated at pre-pubertal stages of organogenesis, when androgen levels are low, and that the
transcription factor Ascl1 is essential for formation of prostate neuroendocrine cells. To complement these
analyses, we have also performed studies of neuroendocrine differentiation in prostate tumors through single-
cell RNA-sequencing of mouse CRPC tumors and organoid models to identify candidate non-cell autonomous
interactions that may regulate neuroendocrine differentiation, as well as computational analyses to identify novel
candidate master regulators of neuroendocrine differentiation in tumors. Importantly, we have obtained evidence
for a non-cell autonomous role for extrinsic signals from the microenvironment in promoting neuroendocrine
differentiation of prostate tumor cells.
Based on our preliminary data, we hypothesize that neuroendocrine differentiation in both normal and
tumor contexts is governed by extrinsic signals from the environment in response to low AR activity in order to
regulate intrinsic pathways of neuroendocrine specification. To investigate this hypothesis, we will pursue an
innovative combination of in vivo, ex vivo, molecular, and computational analyses that are organized in three
synergistic specific aims: (1) Investigation of Ascl1 in prostate development and cancer to pursue comparative
analyses of its role in normal and tumor contexts; (2) Investigation of intrinsic regulators of neuroendocrine
differentiation in prostate cancer using computational systems approaches to identify candidate master
regulators followed by their functional validation; and (3) Analysis of stromal signals that promote neuroendocrine
differentiation in response to androgen deprivation to evaluate the role of candidate signaling factors from the
microenvironment in modulating neuroendocrine differentiation in response to AR in organogenesis and prostate
cancer. These studies will have strong translational impact through the identification of molecular targets that
are specific for neuroendocrine prostate cancer. Furthermore, this project will be highly integrated with the other
components of this program project through collaborative interactions with the Sawyers lab in analyzing
microenvironmental signals, with the Abate-Shen lab in studies of mouse models, with Core A in analysis of
human tissue samples, and Core B for statistical support and data management,
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core B: Administrative and Data Management Core
-
批准号:10333946
-
项目类别:
-
资助金额:$52.55万
-
财政年份:2022
-
负责人:MICHAEL M. SHEN
-
依托单位:
Project 3: Analysis of intrinsic and extrinsic factors that promote prostate neuroendocrine differentiation
-
批准号:10333945
-
项目类别:
-
资助金额:$63.91万
-
财政年份:2022
-
负责人:MICHAEL M. SHEN
-
依托单位:
Investigating cell-intrinsic and extrinsic interactions in prostate cancer at the single cell level
-
批准号:10612346
-
项目类别:
-
资助金额:$205.58万
-
财政年份:2022
-
负责人:MICHAEL M. SHEN
-
依托单位:
Core B: Administrative and Data Management Core
-
批准号:10612361
-
项目类别:
-
资助金额:$25.36万
-
财政年份:2022
-
负责人:MICHAEL M. SHEN
-
依托单位:
Investigating cell-intrinsic and extrinsic interactions in prostate cancer at the single cell level
-
批准号:10333942
-
项目类别:
-
资助金额:$305.25万
-
财政年份:2022
-
负责人:MICHAEL M. SHEN
-
依托单位:
Genetic Approaches to Development and Disease
-
批准号:10206946
-
项目类别:
-
资助金额:$39.01万
-
财政年份:2021
-
负责人:MICHAEL M. SHEN
-
依托单位:
Investigating lineage plasticity in castration-resistant prostate cancer
-
批准号:10441364
-
项目类别:
-
资助金额:$41.93万
-
财政年份:2020
-
负责人:MICHAEL M. SHEN
-
依托单位:
Investigating lineage plasticity in castration-resistant prostate cancer
-
批准号:10656234
-
项目类别:
-
资助金额:$41.93万
-
财政年份:2020
-
负责人:MICHAEL M. SHEN
-
依托单位:
Investigating lineage plasticity in castration-resistant prostate cancer
-
批准号:10033614
-
项目类别:
-
资助金额:$42.79万
-
财政年份:2020
-
负责人:MICHAEL M. SHEN
-
依托单位:
Investigating lineage plasticity in castration-resistant prostate cancer
-
批准号:10164741
-
项目类别:
-
资助金额:$42.79万
-
财政年份:2020
-
负责人:MICHAEL M. SHEN
-
依托单位:
Analysis of epithelial heterogeneity in prostate development and cancer
-
批准号:10378051
-
项目类别:
-
资助金额:$41.1万
-
财政年份:2019
-
负责人:MICHAEL M. SHEN
-
依托单位:
Analysis of epithelial heterogeneity in prostate development and cancer
-
批准号:10599886
-
项目类别:
-
资助金额:$41.19万
-
财政年份:2019
-
负责人:MICHAEL M. SHEN
-
依托单位:
Core B: Bladder Cancer Models Core
-
批准号:10475026
-
项目类别:
-
资助金额:$18.52万
-
财政年份:2018
-
负责人:MICHAEL M. SHEN
-
依托单位:
Core B: Bladder Cancer Models Core
-
批准号:10218083
-
项目类别:
-
资助金额:$20.17万
-
财政年份:2018
-
负责人:MICHAEL M. SHEN
-
依托单位:
Project 3: Modeling tumor evolution and drug response in bladder cancer organoids
-
批准号:10475018
-
项目类别:
-
资助金额:$28.9万
-
财政年份:2018
-
负责人:MICHAEL M. SHEN
-
依托单位:
Project 3: Modeling tumor evolution and drug response in bladder cancer organoids
-
批准号:10218080
-
项目类别:
-
资助金额:$36.98万
-
财政年份:2018
-
负责人:MICHAEL M. SHEN
-
依托单位:
Systems analysis of mouse gastrulation
-
批准号:9906071
-
项目类别:
-
资助金额:$33.04万
-
财政年份:2016
-
负责人:MICHAEL M. SHEN
-
依托单位:
Systems analysis of mouse gastrulation
-
批准号:9312134
-
项目类别:
-
资助金额:$33.04万
-
财政年份:2016
-
负责人:MICHAEL M. SHEN
-
依托单位:
Modeling human prostate cancer by cellular reprogramming
-
批准号:9107829
-
项目类别:
-
资助金额:$20.88万
-
财政年份:2015
-
负责人:MICHAEL M. SHEN
-
依托单位:
Molecular mechanisms of prostate cancer initiation
-
批准号:8538769
-
项目类别:
-
资助金额:$124.73万
-
财政年份:2011
-
负责人:MICHAEL M. SHEN
-
依托单位:
海外基金